Chronic liver disease in Europe: a preventable crisis going undetected
Barcelona Institute for Global Health (ISGlobal)Peer-Reviewed Publication
This four-paper Series and accompanying comments examine the growing but under-recognised burden of chronic liver disease in Europe, with a focus on steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease, and alcohol-related liver disease, along with viral hepatitis B and C. The Series provides country-level data on MASLD policies, analyses systemic failures in prevention, timely detection, and equitable access to care across diverse populations and health systems; and evaluates policy gaps, health system responses, and innovations in diagnostics, care models, and public health strategies. The Series calls for the rapid integration of metabolic liver health into non-communicable disease frameworks, strengthened surveillance and care pathways, and coordinated, equity-driven, and preventative approaches to identify the “missing millions” and reduce the rising human and economic toll of chronic liver disease across the region.
- Journal
- The Lancet Regional Health - Europe